These subtypes are characterized by differential expression of hepatic stem/progenitor markers (LIN28B, SALL4, AFP), hepatobiliary markers (HNF, NOTCH1), metabolic factors (NFE2L2), and cancer-related pathways (P53, TERT). The gene discussed is TP53; the disease is cancer.